Prevalence of anaemia and immunological markers among Ghanaian HAART-naïve HIV-patients and those on HAART

African Health Sciences

Volumn 11, Issue 1, 2011, Pages 2-15

  Owiredu, William K B A ^a   Quaye, L ^a   Amidu, N ^a   Addai Mensah, O ^a  

^a KWAME NKRUMAH UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Ghana)

Author keywords

Antiretroviral; CD4; Lymphocyte; TLC; WHO ACTG

Indexed keywords

ANTIRETROVIRUS AGENT; BIOLOGICAL MARKER; HEMOGLOBIN; HUMAN IMMUNODEFICIENCY VIRUS PROTEINASE INHIBITOR; NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; RNA DIRECTED DNA POLYMERASE;

ADULT; AGE DISTRIBUTION; AGED; ANEMIA; ARTICLE; BLOOD ANALYSIS; BODY WEIGHT; CAUSE OF DEATH; CD3+ T LYMPHOCYTE; CD4 LYMPHOCYTE COUNT; CHILD; CLINICAL ASSESSMENT; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DRUG EFFICACY; FEMALE; GHANA; HEMATOCRIT; HEMOGLOBIN BLOOD LEVEL; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGICAL MONITORING; INFANT; IRON DEFICIENCY ANEMIA; LYMPHOCYTOPENIA; MACROCYTIC ANEMIA; MAJOR CLINICAL STUDY; MALE; NEUTROPENIA; POLYPOIDAL CHOROIDAL VASCULOPATHY; PREDICTION; SCHOOL CHILD; SEX DIFFERENCE; THROMBOCYTOPENIA; VIRUS LOAD;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ANEMIA; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; CHILD, PRESCHOOL; FEMALE; GHANA; HEMATOCRIT; HEMATOLOGIC TESTS; HIV INFECTIONS; HUMANS; INFANT; INFANT, NEWBORN; LYMPHOPENIA; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PREVALENCE; SEX DISTRIBUTION; YOUNG ADULT;

EID: 79953764941     PISSN: 16806905     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Okolie MN, Eghafona NO, Omoregie R. Anti-human immunodeficiency virus agents. Journal of Medical Laboratory Science 2003;12:1-14.
2. Voth R, Rossol S, Graff E, Laubenstein HP, Schroder HC, Muller WE, Meyer zum Buschenfelde KH, Hess G. Natural killer cell activity as a prognostic parameter in the progression to AIDS. J Infect Dis 1988;157(4):851-2.
3. Tersmette M, Schuitemaker H. Virulent HIV strains? AIDS 1993;7(8):1123-5.
4. Coyle T.E. Hematologic complications of human immunodeficiency virus infection and the acquired immunodeficiency syndrome. Med Clin North Am 1997;81(2):449-70.
5. Salond E. Haematologic complications of HIV infection. AIDS Rev 2005;7:187-96.
6. Cosby C.D. Hematologic disorders associated with human immunodeficiency virus and AIDS. J Infus Nurs 2007;30(1):22-32.
7. Moyle G. Anaemia in persons with HIV infection: prognostic marker and contributor tomorbidity. AIDS Rev 2002;4(1):13-20.
8. Volberding P. The impact of anemia on quality of life in human immunodeficiency virus-infected patients. J Infect Dis 2002;185 Suppl 2:S110-4.
9. Odunukwe N, Idigbe O, Kanki P, Adewole T, Onwujekwe D, Audu R, Onyewuche J. Haematological and biochemical response to treatment of HIV-1 infection with a combination of nevirapine + stavudine + lamivudine in Lagos, Nigeria. Turkish Journal of Haematology 2005;22:125-131.
10. Gea-Banacloche JC, Lane HC. Immune reconstitution in HIV-1 infections. AIDS 1999;13:525-538.
11. Omoregie R, Egbeobauwaye A, Ogefere H, Omokaro EU, Ekeh CC. Prevalence of Antibodies to HAART Agents among HIV Patients in Benin city, Nigeria. African Journal of Biomedical Research 2008;11:33-37.
12. Amballi AA, Ajibola A, Ogun SA, Ogunkolo OF., Salu LO., Oritogun KS., Oyegunle VA. Demographic pattern and haematological profile in people living with HIV/AIDS in a university teaching hospital. Scientific Research and Essay 2007;2(8):315-318.
13. De Cock KM, Barrere B, Diaby L, Lafontaine MF, Gnaore E, Porter A, Pantobe D, Lafontant GC., Dago-Akribi A, Ette M, et al. AIDS-the leading cause of adult death in the West African City of Abidjan, Ivory Coast. Science 1990;249(4970):793-6.
14. Ryder RW, Rayfield M, Quinn T. Transplacental HIV transmission in African newborns. 1998.
15. Amornkul P.N., Vandenhoudt H., Nasokho P., Odhiambo F., Mwaengo D., Hightower A., Buve A., Misore A., Vulule J., Vitek C., Glynn J., Greenberg A., Slutsker L., De Cock K.M. HIV prevalence and associated risk factors among individuals aged 13-34 years in Rural Western Kenya. PLoS One 2009;4(7):e6470.
16. Ghana AIDS Commission. Ghana HIV/AIDS strategic framework: 2001-2005. In. Accra, Ghana: Ghana AIDS Commission; 2001.
17. Dabis F, Ekpini ER. HIV-1/AIDS and maternal and child health in Africa. Lancet 2002;359(9323):2097-104.
18. WHO. AIDS epidemic update: December 2004. In. Geneva; 2004:87.
19. WHO. Antiretroviral therapy for HIV infection in adults and adolescents in resource-limited settings: towards universal access. Recommendations for a public health approach (2006 revision). 2006.
20. Woods MN, Spiegelman D, Knox TA, Forrester JE, Connors JL, Skinner SC, Silva M, Kim JH, Gorbach SL. Nutrient intake and body weight in a large HIV cohort that includes women and minorities. J Am Diet Assoc 2002;102(2):203-11.
21. Oguntibeju OO, Van Den Heever WM, Van Schalkwyk F.E. Effect of a liquid nutritional supplement on viral load and haematological parameters in HIV-positive/ AIDS patients. Br J Biomed Sci 2006;63(3):134-9.
22. Bouic PJ, Clark A, Brittle W., Lamprecht JH., Freestone M., Liebenberg R.W. Plant sterol/sterolin supplement use in a cohort of South African HIV-infected patients-effects on immunological and virological surrogate markers. S Afr Med J 2001;91(10):848-50.
23. Moore RD, Keruly JC, Chaisson RE. Anemia and survival in HIV infection. J Acquir Immune Defic Syndr Hum Retrovirol 1998;19(1):29-33.
24. Mocroft A, Kirk O, Barton SE, Dietrich M, Proenca R, Colebunders R, Pradier C, dArminio Monforte A, Ledergerber B., Lundgren J.D. Anaemia is an independent predictive marker for clinical prognosis in HIV-infected patients from across Europe. EuroSIDA study group. AIDS 1999;13(8):943-50.
25. Levine AM, Berhane K, Masri-Lavine L, Sanchez M., Young M., Augenbraun M., Cohen M., Anastos K., Newman M., Gange S.J., Watts H. Prevalence and correlates of anemia in a large cohort of HIV-infected women: Women's Interagency HIV Study. J Acquir Immune Defic Syndr 2001;26(1):28-35.
26. Belperio PS, Rhew DC. Prevalence and outcomes of anemia in individuals with human immunodeficiency virus: a systematic review of the literature. Am J Med 2004;116 Suppl 7A:27S-43S.
27. Abrams DI., Steinhart C, Frascino R. Epoetin alfa therapy for anaemia in HIV-infected patients: impact on quality of life. Int J STD AIDS 2000;11(10):659-65.
28. Volberding P.A., Levine A.M., Dieterich D., Mildvan D., Mitsuyasu R., Saag M. Anemia in HIV infection: clinical impact and evidence-based management strategies. Clin Infect Dis 2004;38(10):1454-63.
29. Omoregie R., Omokaro E.U., Palmer O., Ogefere H.O., Egbeobauwaye A., Adeghe J.E., Osakue S.I., Ihemeje V. Prevalence of anaemia among HIV-infected patients in Benin City, Nigeria. Tanzania Journal of Health Research 2009;11(1).
30. Burkes RL, Cohen H., Krailo M., Sinow R.M., Carmel R. Low serum cobalamin levels occur frequently in the acquired immune deficiency syndrome and related disorders. Eur J Haematol 1987;38(2):141-7.
31. Beach RS., Mantero-Atienza E., Eisdorfer C., Fordyce-Baum M.K. Altered folate metabolism in early HIV infection. JAMA 1988;259(4):519.
32. oudes P., Zittoun J., Sobel A. Folate, vitamin B12, and HIV infection. Lancet 1990;335(8702):1401-2.
33. Hepburn MJ, Dyal K, Runser LA., Barfield RL., Hepburn LM, Fraser SL. Low serum vitamin B12 levels in an outpatient HIV-infected population. Int J STD AIDS 2004;15(2):127-33.
34. Remacha AF, Cadafalch J. Cobalamin deficiency in patients infected with the humanimmunodeficiency virus. Semin Hematol 1999;36(1):75-87.
35. Gougeon ML, Montagnier L. Apoptosis in AIDS. Science 1993;260(5112):1269-70.
36. L., Martinez G., Gonzalez I., Tarinas A., Alvarez A., Giuliani A., Molina R., Tapanes R., Perez J., Leon OS. Contribution to characterization of oxidative stress in HIV/AIDS patients. Pharmacol Res 2003;47(3):217-24.
37. Obirikorang C, Yeboah FA. Blood haemoglobin measurement as a predictive indicator for the progression of HIV/AIDS in resource-limited setting. Journal of Biomedical Science 2009;16:102.
38. Curkendall SM, Richardson JT., Emons MF, Fisher AE, Everhard F. Incidence of anaemia among HIVinfected patients treated with highly active antiretroviral therapy. HIV Med 2007;8(8):483-90.
39. Attili SVS, Singh VP, Rai M, Varma DV, Gulati AK, Sundar S. Hematological profile of HIV patients in relation to immune status-a hospital-based cohort from Varanasi, North India. Turk Journal of Hematology 2008;25(1).
40. Pechere M, Samii K, Hirschel B. HIV-related thrombocytopenia. N Engl J Med 1993;328(24):1785-6
41. Mwamburi DM., Ghosh M., Fauntleroy J., Gorbach S.L., Wanke C.A. Predicting CD4 count using total lymphocyte count: a sustainable tool for clinical decisions during HAART use. Am J Trop Med Hyg 2005;73(1):58-62.
42. Crowe S, Turnbull S, Oelrichs R, Dunne A. Monitoring of human immunodeficiency virus infection in resource-constrained countries. Clin Infect Dis 2003;37(Suppl 1):S25-35.
43. Kumarasamy N, Mahajan AP., Flanigan TP., Hemalatha R., Mayer K.H., Carpenter C.C., Thyagarajan S.P., Solomon S. Total lymphocyte count (TLC) is a useful tool for the timing of opportunistic infection prophylaxis in India and other resource-constrained countries. J Acquir Immune Defic Syndr 2002;31(4):378-83.
44. van der Ryst E, Kotze M, Joubert G, Steyn M, Pieters H., van der Westhuizan M., van Staden M., Venter C. correlation among total lymphocyte count, absolute CD4+ percentage in a group of HIV-1 infected South African Patients. JAIDS Human Retroviral 1998;19:238-244.
45. Schreibman T, Friedland G. Use of total lymphocyte count for monitoring response to antiretroviral therapy. Clin Infect Dis 2004;38(2):257-62.